Literature DB >> 29067114

Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.

Hao Cheng1, Yiming Pan1, Yongzhong Yao1, Zhanghua Zhu2, Jun Chen3, Xitai Sun1, Yudong Qiu1, Yitao Ding1.   

Abstract

Caveolin-1 (Cav-1) is a major component of caveolae and has been recently identified as a tumor suppressor. As little is known about Cav-1 in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC), the aim of the present study was to investigate the expression and significance of Cav-1 in HBV-associated HCC. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the mRNA expression level of Cav-1 in 40 cases of HBV-associated HCC, the corresponding 11 non-tumor cases of HBV-associated chronic hepatitis, 29 non-tumor cases of HBV-associated cirrhosis and 6 cases of normal liver tissues. Immunohistochemical analysis indicated the expression of Cav-1, cluster of differentiation 34 and vascular endothelial growth factor (VEGF) in HBV-associated HCC tissue samples. In addition, the association of Cav-1 expression with angiogenesis and clinicopathological characteristics of HBV-associated HCC was also analyzed. RT-PCR results demonstrated that the expression rate of Cav-1 mRNA in HBV-associated HCC, non-tumor HBV-associated chronic hepatitis and cirrhosis liver tissues and control normal liver tissues from patients with metastatic carcinoma was 92.5, 85.0 and 16.7%, respectively. mRNA expression level of Cav-1 was significantly increased in chronic hepatitis, cirrhosis and HBV-associated HCC livers compared with normal control livers (P<0.05 and P<0.01, respectively). Cav-1 protein was detected by immunohistochemistry in 80% of the samples of HBV-associated HCC. Furthermore, Cav-1 and VEGF protein expression levels were correlated with microvessel density (MVD; γs<0.46, P=0.01 and γs<0.31, P=0.05, respectively). In addition, Cav-1 expression and MVD were significantly associated with metastasis (P=0.031 and P=0.046, respectively). In conclusion, Cav-1 may have an important role in the carcinogenesis and progression of HBV-associated HCC and angiogenesis may be affected by Cav-1 during this process.

Entities:  

Keywords:  angiogenesis; caveolin-1; hepatocellular carcinoma; microvessel density

Year:  2017        PMID: 29067114      PMCID: PMC5647718          DOI: 10.3892/etm.2017.5038

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  43 in total

Review 1.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

2.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.

Authors:  J Liu; B Razani; S Tang; B I Terman; J A Ware; M P Lisanti
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

4.  Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).

Authors:  Lukman Bin Md Auzair; Vui King Vincent-Chong; Wan Maria Nabillah Ghani; Thomas George Kallarakkal; Anand Ramanathan; Chia Ee Lee; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Mannil Thomas Abraham; Rosnah Binti Zain
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-03       Impact factor: 2.503

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Caveolin and thrombospondin expression during hepatocellular carcinogenesis.

Authors:  Lisa M Yerian; Robert A Anders; Maria Tretiakova; John Hart
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

7.  Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.

Authors:  Pierre Sonveaux; Philippe Martinive; Julie DeWever; Zuzana Batova; Géraldine Daneau; Michel Pelat; Philippe Ghisdal; Vincent Grégoire; Chantal Dessy; Jean-Luc Balligand; Olivier Feron
Journal:  Circ Res       Date:  2004-06-17       Impact factor: 17.367

8.  Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.

Authors:  Satoru Sugie; Shoichiro Mukai; Koji Yamasaki; Toyoharu Kamibeppu; Hiromasa Tsukino; Toshiyuki Kamoto
Journal:  Cancer Genomics Proteomics       Date:  2015 Nov-Dec       Impact factor: 4.069

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Regulation of Cell Signaling and Function by Endothelial Caveolins: Implications in Disease.

Authors:  Grzegorz Sowa
Journal:  Transl Med (Sunnyvale)       Date:  2012-01-04
View more
  2 in total

1.  Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival.

Authors:  Anna Maria Posadino; Roberta Giordo; Annalisa Cossu; Gheyath K Nasrallah; Abdullah Shaito; Haissam Abou-Saleh; Ali H Eid; Gianfranco Pintus
Journal:  Biomolecules       Date:  2019-05-30

Review 2.  Multifaceted Functions of Host Cell Caveolae/Caveolin-1 in Virus Infections.

Authors:  Yifan Xing; Zeyu Wen; Wei Gao; Zhekai Lin; Jin Zhong; Yaming Jiu
Journal:  Viruses       Date:  2020-04-26       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.